TATAA Biocenter and Strand Life Sciences Announce Strategic Partnership
News Jun 24, 2015
TATAA Biocenter has partnered with Strand Life Sciences to advance the analysis of Next Generation Sequencing (NGS) data.
As part of the partnership, TATAA Biocenter will distribute and support Strand NGS, Strand’s premier analysis tool for NGS data, in Europe. TATAA is also going to use Strand NGS in its popular NGS training courses.
“We always seek collaboration with the best solution providers for our training courses and Strand Life Sciences are top of the class for NGS whole transcriptome profiling”, says Kristina Lind, coordinator of TATAA Biocenter’s hands-on training program. “Our customers request professional tools for the entire NGS workflow from sample preparation, quality control, library preparation, sequencing and data analysis.”, says Mikael Kubista, president of TATAA Biocenter, “With Strand NGS our customers obtain the most comprehensive and powerful tool for the analysis of Next Generation Sequencing data”.
“We have always welcomed collaborations for serving the customer better and for the greater good of science. Tataa Biocenter is an established player in Europe with a wide reach. European customers will now have access to one of the most comprehensive, commercially available, NGS analysis tools” says Scott Storrer, President of Strand Life Science.
Scientists at McGill have found the answer to a question that perplexed Charles Darwin; if natural selection works at the level of the individual, fighting for survival and reproduction, how can a single colony produce worker ants that are so dramatically different in size – from “minor” workers to large-headed soldiers with huge mandibles – especially if they are sterile?
Scientists have developed a successful method to make truly personalized predictions of future disease outcomes for patients with certain types of chronic blood cancers. The study combined extensive genetic and clinical information to predict the prognosis for patients with myeloproliferative neoplasms.
For centuries, gardeners have attempted to breed blue roses with no success. But now, thanks to modern biotechnology, the elusive blue rose may finally be attainable. Researchers have found a way to express pigment-producing enzymes from bacteria in the petals of a white rose, tinting the flowers blue.
2nd International Conference on Computational Biology and Bioinformatics
May 17 - May 18, 2019
2nd World Congress on Genetics & Genetic Disorders
May 13 - May 14, 2019